Enzymatic Modifications of Fibrinolytic Enzyme and Inhibitor Molecules

• References

• 1 Sumi H, Kosugi T, Matsuo O, Mihara H. Physicochemical properties of highly purified kidney cultured plasminogen activator (single-chain urokinase). Acta Haematol Jpn 1982; 45: 119-128
• 2 Sumi H, Robbins KC. The preparation and characterization of a functionally active urokinase heavy chain prepared from high molecular weight urokinase. In: Davidson JF, Nilsson IM, Åstedt B. (Eds): Progress in Fibrinolysis Churchill Livingstone; Edinburgh: 1981. 5 36-37
• 3 Sumi H, Toki N, Maehara S, Kosugi T, Akazawa K, Matsuo O, Mihara H. Immunochemical studies of high and low molecular forms of urokinase. Acta Haematol (Basel). 1982 in press
• 4 Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: Isolation of two lysine-binding fragments and one “mini-plasminogen”? (MW, 38,000) by elastase-catalyzed-specific limited proteolysis. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC. (Eds) Progress in Chemical Fibrinolysis and Thrombolysis. Vol. 3 Raven Press; New York: 1978: 191-209
• 5 Toki N, Takasugi S, Ishizu K, Sato H, Sumi H. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase. Thromb Haemostas 1982; 47: 8-13
• 6 Toki N, Maehara S, Hayashi M, Ukai R, Sumi H. Further purification and some properties of human urinary tyrpsin inhibitor. Invest Urol 1980; 17: 465-469